Skip to main content

Find Clinical Trials

Home
Conditions
Kidney Neoplasms

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies

Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Not Yet Recruiting

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

NCT07578025

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not Yet Recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details

Not Yet Recruiting

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

NCT07500805

Conditions: Adenocarcinoma, CD70-positive Advanced Renal Clear Cell Carcinoma, Carcinoma, +14 more
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

NCT07500831

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations: Qilu Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

NCT07497958

Conditions: Acute Kidney Injury, Adenocarcinoma, Carcinoma, +17 more
Locations: 651 Dongfeng Road East, Yuexiu District, Guangzhou, P.R. China Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

NCT07494435

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: China Pharmaceutical University, Shanghai Gobroad Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

NCT07470840

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

View Trial Details

Not Yet Recruiting

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

NCT07480044

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +33 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients

NCT07465458

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: IRCCS Ospedale San Raffaele Milan, Milano, Italy

Fondazione Poliambulanza Istituto Ospedaliero Brescia, Italy

Istituto Europeo di Onclologia ( IEO) Milan, Italy

Policlinico Universitario Campus Bio-Medico Roma, Italy

View Trial Details

Not Yet Recruiting

Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment

NCT07460206

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details